MOSCOW, Sept 27 (Reuters) - A small-scale scientific examine of the combined use of the AstraZeneca and Sputnik easy vaccines in opposition t COVID-19 has shown amazing antibody boom in a majority of the study's individuals, the Russian Direct funding Fund noted on Monday.
The records was accumulated from 20 people who took half in a 100-grownup look at in Azerbaijan that begun in February. They first acquired the AstraZeneca shot adopted through the one-dose Russian-made Sputnik mild shot 29 days later, RDIF stated.
"in response to the results of the intervening time evaluation, a fourfold or higher enhance in neutralizing antibodies to the spike protein (S-protein) of the SARS-CoV-2 was found in 85% of the volunteers on the 57th day of the look at," RDIF observed.
(Reporting through Maxim Rodionov; Writing by Alexander Marrow; enhancing via Louise Heavens)
0 Comments